We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
Collection content
305 result(s) found, displaying 11 to 20
-
GuidanceGuidance relating to the supply of in vitro diagnostic medical devices for the detection of COVID-19/SARS-CoV-2 infections.
-
GuidanceGuidance clarifying the interaction between our requirements and AHPRA advertising guidelines.
-
PageAnswers to frequently asked questions in relation to rapid antigen point-of-care tests.
-
PageBatch release testing of biological medicines (excluding vaccines) is no longer required.
-
PageTo enable timely distribution of COVID-19 treatments, international labels may be used during initial supply in Australia.
-
PageInformation to assist businesses understand the key considerations for the safe implementation of COVID-19 rapid antigen point-of-care testing in their workplace.
-
PageExplore FAQs for new sponsors about the supply of disinfectant products.
-
GuidanceGuidance to assist manufacturers of medical devices and their component parts with meeting their regulatory obligations.
-
PageWe have identified disinfectants as being critical in preventing the spread of COVID-19. This information provides advice on how to use disinfectants properly.
-
PageUnderstand how disinfectants are regulated and how to supply them.